Outcomes in Severe Osteoporotic Women in Korea Using Sequential Treatment
Value Health
.
2014 Nov;17(7):A771.
doi: 10.1016/j.jval.2014.08.317.
Epub 2014 Oct 26.
Authors
B R M Kim
1
,
R Burge
2
,
T M Klein
3
,
L J Smolen
3
Affiliations
1
Lilly Korea Ltd., Seoul, South Korea.
2
Eli Lilly and Company, Indianapolis, IN, USA.
3
Medical Decision Modeling Inc., Indianapolis, IN, USA.
PMID:
27202842
DOI:
10.1016/j.jval.2014.08.317
No abstract available